The oncogenic potential of endometrial polyps: A systematic review and meta-analysis

Obstetrics and Gynecology

Volumn 116, Issue 5, 2010, Pages 1197-1205

  Lee, Stephanie Cruz ^a   Kaunitz, Andrew M ^a   Sanchez Ramos, Luis ^a   Rhatigan, Ronald M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM CHLORIDE;

CANCER RISK; CARCINOGENICITY; COCHRANE LIBRARY; DATA BASE; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ENDOMETRIUM POLYP; HISTOPATHOLOGY; HUMAN; HYSTEROGRAPHY; HYSTEROSCOPY; MALIGNANT NEOPLASTIC DISEASE; MEDICAL LITERATURE; MEDLINE; MENOPAUSE; OBSERVATIONAL STUDY; POLYPECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ULTRASOUND; UTERUS BLEEDING; VAGINA BLEEDING; COMPLICATION; ENDOMETRIAL NEOPLASMS; FEMALE; META ANALYSIS; PATHOLOGY; POLYP; PRECANCER; RISK FACTOR; UTERINE NEOPLASMS;

ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MENOPAUSE; POLYPS; PRECANCEROUS CONDITIONS; RISK FACTORS; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

EID: 78049338870     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181f74864     Document Type: Review

References (61)

1. Perez-Medina T, Bajo J, Huertas MA, Rubio A. Predicting atypia inside endometrial polyps. J Ultrasound Med 2002;21: 125-8.
2. Syrop CH, Sahakian V. Transvaginal sonographic detection of endometrial polyps with fluid contrast augmentation. Obstet Gynecol 1992;79:1041-3.
3. Shalev J, Meizner I, Bar-Hava I, Dicker D, Mashiach R, Ben-Rafael Z. Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility. Fertil Steril 2000;73:412-7.
4. La Torre R, De Felice C, De Angelis C, Coacci F, Mastrone M, Cosmi EV. Transvaginal sonographic evaluation of endome-trial polyps: a comparison with two dimensional and three dimensional contrast sonography. Clin Exp Obstet Gynecol 1999;26:171-3.
5. Muzaffar M, Akhtar KA, Yasmin S, Mahmood-Ur-Rehman, Iqbal W, Khan MA. Menstrual irregularities with excessive blood loss: a clinico-pathological correlation. J Pak Med Assoc 2005;55:486-9.
6. Descargues G, Lemercier E, David C, Genevois A, Lemoine JP, Marpeau L. Which initial tests should be performed to evaluate meno-metrorrhagias? A comparison of hysterogra-phy, transvaginal sonohysterography and hysteroscopy [French]. J Gynecol Obstet Biol Reprod (Paris) 2001;30: 59-64.
7. Pal L, Niklaus AL, Kim M, Pollack S, Santoro N. Heterogeneity in endometrial expression of aromatase in polyp-bearing uteri. Hum Reprod 2008;23:80-4.
8. Maia H Jr, Pimentel K, Silva TM, Freitas LA, Zausner B, Athayde C, et al. Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle. Gynecol Endocrinol 2006;22:219-24.
9. Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 2000;80:359-69.
10. Fletcher JA, Pinkus JL, Lage JM, Morton CC, Pinkus GS. Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp. Genes Chromosomes Cancer 1992;5:260-3.
11. Dal Cin P, Wanschura S, Kazmierczak B, Tallini G, Dei Tos A, Bullerdiek J, et al. Amplification and expression of the HMGIC gene in a benign endometrial polyp. Genes Chromosomes Cancer 1998;22:95-9.
12. Dal Cin P, Vanni R, Marras S, Moerman P, Kools P, Andria M, et al. Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 1995;155:1565-8.
13. Bol S, Wanschura S, Thode B, Deichert U, Van de Ven WJ, Bartnitzke S, et al. An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 1996;90:88-90.
14. Ben-Arie A, Goldchmit C, Laviv Y, Levy R, Caspi B, Huszar M, et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 2004;115:206-10.
15. DeWaay DJ, Syrop CH, Nygaard IE, Davis WA, Van Voorhis BJ. Natural history of uterine polyps and leiomyomata. Obstet Gynecol 2002;100:3-7.
16. Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol 1990;9:1-19.
17. Hattab EM, Allam-Nandyala P, Rhatigan RM. The stromal component of large endometrial polyps. Int J Gynecol Pathol 1999;18:332-7.
18. Kassab A, Trotter P, Fox R. Risk of cancer in symptomatic postmenopausal women with endometrial polyps at scan. J Obstet Gynaecol 2008;28:522-5.
19. Goldstein SR, Monteagudo A, Popiolek D, Mayberry P, Timor-Tritsch I. Evaluation of endometrial polyps. Am J Obstet Gynecol 2002;186:669-74.
20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12.
21. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2nd, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:812-9.
22. Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 1999;23:1102-8.
23. Fox H, Buckley CH. The endometrial hyperplasias and their relationship to endometrial neoplasia. Histopathology 1982;6: 493-510.
24. DerSirmonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
27. Breslow NE, Day NE. Statistical methods in cancer research. Volume I\-The analysis of case-control studies. IARC Sci Publ 1980:5-338.
28. L'Abbé KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987;107:224-33.
29. Wang JH, Zhao J, Lin J. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. J Minim Invasive Gynecol 2010;17:53-8.
30. Shushan A, Revel A, Rojansky N. How often are endometrial polyps malignant? Gynecol Obstet Invest 2004;58:212-5.
31. Savelli L, De Iaco P, Santini D, Rosati F, Ghi T, Pignotti E, et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 2003;188:927-31.
32. Rahimi S, Marani C, Renzi C, Natale ME, Giovannini P, Zeloni R. Endometrial polyps and the risk of atypical hyper-plasia on biopsies of unremarkable endometrium: a study on 694 patients with benign endometrial polyps. Int J Gynecol Pathol 2009;28:522-8.
33. Orvieto R, Bar-Hava I, Dicker D, Bar J, Ben-Rafael Z, Neri A. Endometrial polyps during menopause: characterization and significance. Acta Obstet Gynecol Scand 1999;78:883-6.
34. Martinez MA, Jou P, Novell R, Cardona M. Endometrial polyps: risk of transformation and clinico-anatomic correlation. Prog Obstet Ginecol 2004;11:506-10.
35. Lieng M, Qvigstad E, Sandvik L, Jorgensen H, Langebrekke A, Istre O. Hysteroscopic resection of symptomatic and asymptomatic endometrial polyps. J Minim Invasive Gynecol 2007; 14:189-94.
36. Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, Papadias K, et al. Clinical parameters linked with malignancy in endometrial polyps. Climacteric 2009;12:454-8.
37. Ferrazzi E, Zupi E, Leone FP, Savelli L, Omodei U, Moscarini M, et al. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Am J Obstet Gynecol 2009;200:235.e1-6.
38. Fernandez-Parra J, Rodriguez Oliver A, Lopez Criado S, Parrilla Fernandez F, Montoya Ventoso F. Hysteroscopic evaluation of endometrial polyps. Int J Gynaecol Obstet 2006;95:144-8.
39. Dreisler E, Stampe Sorensen S, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol 2009;33:102-8.
40. Domingues AP, Lopes H, Dias I, De Oliveira CF. Endometrial polyps in postmenopausal women. Acta Obstet Gynecol Scand 2009;88:618-20.
41. Baiocchi G, Manci N, Pazzaglia M, Giannone L, Burnelli L, Giannone E, et al. Malignancy in endometrial polyps: a 12-year experience. Am J Obstet Gynecol 2009;201:462.e1-4.
42. Antunes A Jr, Costa-Paiva L, Arthuso M, Costa JV, Pinto-Neto AM. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy. Maturitas 2007;57:415-21.
43. Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol 2000;21:180-3.
44. Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, Duggan MA, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010;28:788-92.
45. Giuntoli R JM, Zacur H. Endometrial hyperplasia. UpToDate. September 2009.
46. Egger M, Zellweger-Zahner T, Schneider M, Junker C, Len-geler C, Antes G. Language bias in randomised controlled trials published in English and German. Lancet 1997;350: 326-9.
47. Gregoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995;48:159-63.
48. Tate S, Yamazawa K, Sekiya S. Endometrial cancer within tamoxifen-related polyps in patients with breast cancer. Acta Obstet Gynecol Scand 2004;83:769-70.
49. Ravazoula P, Androutsopoulos G, Zyli P, Michail G, Karda-makis DM, Kourounis G. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience. Breast J 2006;12: 578-84.
50. Qureshi A, Bukhari F, Pervez S. Spectrum of tamoxifen associated endometrial pathology in breast cancer patients. J Pak Med Assoc 2009;59:249-50.
51. Morgan RW. Risk of endometrial cancer after tamoxifen treatment. Oncology (Williston Park) 1997;11(suppl 1):25-33.
52. Marsh F, Mayfield M. Tamoxifen and risk of endometrial cancer. Lancet 2001;357:68.
53. Hachisuga T, Emoto M, Kawarabayashi T, Kamihara Y, Nabeshima K. Endometrial cytologic findings in tamoxifen-treated breast cancer patients. Acta Cytol 2009;53:24-8.
54. Garuti G, Cellani F, Centinaio G, Sita G, Nalli G, Luerti M. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer. Gynecol Oncol 2006;101: 269-73.
55. Dibi RP, Zettler CG, Pessini SA, Ayub AV, de Almeida SB, da Silveira GP. Tamoxifen use and endometrial lesions: hystero-scopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer. Menopause 2009; 16:293-300.
56. Chen P, Yang CC, Chen YJ, Wang PH. Tamoxifen-induced endometrial cancer. Eur J Gynaecol Oncol 2003;24:135-7.
57. Buccoliero AM, Fambrini M, Gheri CF, Castiglione F, Garbini F, Barbetti A, et al. Surveillance for endometrial cancer in women on tamoxifen: the role of liquid-based endometrial cytology\-cytohistological correlation in a population of 168 women. Gynecol Obstet Invest 2008;65:240-6.
58. Bland AE, Calingaert B, Secord AA, Lee PS, Valea FA, Berchuck A, et al. Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecol Oncol 2009;112:150-4.
59. Gredmark T, Kvint S, Havel G, Mattsson LA. Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium. Gynecol Oncol 1999;72: 138-42.
60. Folsom AR, Kaye SA, Potter JD, Prineas RJ. Association of incident carcinoma of the endometrium with body weight and fat distribution in older women: early findings of the Iowa Women's Health Study. Cancer Res 1989;49:6828-31.
61. Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A. Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study. Br J Cancer 2008;98:1582-5.